Cardiopulmonary function in individuals with HIV infection in the antiretroviral therapy era

AIDS

Volumn 26, Issue 6, 2012, Pages 731-740

  Morris, Alison ^a,b   Gingo, Matthew R ^a   George, M Patricia ^a   Lucht, Lorrie ^a   Kessinger, Cathy ^a   Singh, Vikas ^a   Hillenbrand, Maria ^a   Busch, Michelle ^a   McMahon, Deborah ^a   Norris, Karen A ^b   Champion, Hunter C ^a   Gladwin, Mark T ^a   Zhang, Yingze ^a   Steele, Chad ^a   Sciurba, Frank C ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

chronic obstructive pulmonary disease; emphysema; HIV; inflammation; pulmonary hypertension

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTIRETROVIRUS AGENT; BIOLOGICAL MARKER; CD69 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 8;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CARDIOPULMONARY FUNCTION; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEART LEFT VENTRICLE FUNCTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SPUTUM ANALYSIS; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE ACTIVATION; TRICUSPID VALVE REGURGITATION; UNIVARIATE ANALYSIS;

BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; CYTOKINES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FORCED EXPIRATORY VOLUME; HIV INFECTIONS; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RESPIRATORY FUNCTION TESTS; RISK FACTORS; RNA, VIRAL; SPUTUM; VITAL CAPACITY;

EID: 84859105143     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32835099ae     Document Type: Article

References (52)

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555. (Pubitemid 47403272)
2. Crothers K, Butt AA, Gibert CL, Rodriguez-Barradas MC, Crystal S, Justice AC. Increased COPD among HIV-positive compared to HIV-negative veterans. Chest 2006; 130:1326-1333. (Pubitemid 44786723)
3. Crothers K, Huang L, Goulet JL, Goetz MB, Brown ST, Rodriguez- Barradas MC, et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med 2011; 183:388-395.
4. Diaz PT, King MA, Pacht ER, Wewers MD, Gadek JE, Nagaraja HN, et al. Increased susceptibility topulmonary emphysema among HIV-seropositive smokers. Ann Intern Med 2000; 132: 369-372. (Pubitemid 30127775)
5. Speich R, Jenni R, Opravil M, Pfab M, Russi EW. Primary pulmonary hypertension inHIV infection. Chest 1991; 100:1268-1271.
6. Sitbon O, Lascoux-Combe C, Delfraissy JF, Yeni PG, Raffi F, De Zuttere D, et al. Prevalence ofHIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. Am J Respir Crit Care Med 2008; 177:108-113.
7. Hsue PY, Deeks SG, Farah HH, Palav S, Ahmed SY, Schnell A, et al. Role ofHIV and human herpesvirus-8 infection in pulmonary arterial hypertension. AIDS 2008; 22:825-833. (Pubitemid 351563831)
8. Mondy KE, Gottdiener J, Overton ET, Henry K, Bush T, Conley L, et al. High prevalence ofechocardiographic abnormalities among HIV-infected persons in the era of highly active anti-retroviral therapy. Clin Infect Dis 2011; 52:378-386.
9. Chaouat A, Bugnet AS, Kadaoui N, Schott R, Enache I, Ducolone A, et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172:189-194. (Pubitemid 40981192)
10. Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension inCOPD. Eur Respir J 2008; 32:1371-1385.
11. Joppa P, Petrasova D, Stancak B, Tkacova R. Systemic inflammation inpatients with COPD and pulmonary hypertension. Chest 2006; 130:326-333. (Pubitemid 44266997)
12. Chaouat A, Savale L, Chouaid C, Tu L, Sztrymf B, Canuet M, et al. Role for interleukin-6 inCOPD-related pulmonary hypertension. Chest 2009; 136:678-687.
13. Gingo MR, George MP, Kessinger CJ, Lucht L, Rissler B, Weinman R, et al. Pulmonary function abnormalities inHIV-infected patients during the current antiretroviral therapy era. Am J Respir Crit Care Med 2010; 182:790-796.
14. Comstock GW, Tockman MS, Helsing KJ, Hennesy KM. Standardized respiratory questionnaires: comparison of the old with the new. Am Rev Respir Dis 1979; 119:45-53. (Pubitemid 9116308)
15. Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, et al. Standardisation ofthe single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26:720-735. (Pubitemid 41448672)
16. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation ofspirometry. Eur Respir J 2005; 26:319-338.
17. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159:179-187. (Pubitemid 29036522)
18. Neas LM, Schwartz J. The determinants ofpulmonary diffusing capacity in a national sample of U.S. adults. Am J Respir Crit Care Med 1996; 153:656-664. (Pubitemid 26051344)
19. Henry WL, DeMaria A, Gramiak R, King DL, Kisslo JA, Popp RL, et al. Report ofthe American Society of Echocardiography Committee on nomenclature and standards in two-dimensional echocardiography. Circulation 1980; 62:212-217. (Pubitemid 10035638)
20. Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for quantification ofDoppler echocardiography: a report from the doppler quantification task force of the nomenclature and standards committee of theAmerican Society of Echocardiography. J AmSoc Echocardiogr 2002; 15:167-184.
21. Yock PG, Popp RL. Noninvasive estimation ofright ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 1984; 70:657-662. (Pubitemid 14020664)
22. Borgeson DD, Seward JB, Miller FA Jr, Oh JK, Tajik AJ. Frequency ofDoppler measurable pulmonary artery pressures. J Am Soc Echocardiogr 1996; 9:832-837.
23. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation ofthe left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2:358-367.
24. Gershman NH, Wong HH, Liu JT, Mahlmeister MJ, Fahy JV. Comparison oftwo methods of collecting induced sputum in asthmatic subjects. Eur Respir J 1996; 9:2448-2453. (Pubitemid 26407891)
25. Fahy JV, Boushey HA, Lazarus SC, Mauger EA, Cherniack RM, Chinchilli VM, et al. Safety and reproducibility ofsputum induction in asthmatic subjects in a multicenter study. Am J Respir Crit Care Med 2001; 163:1470-1475. (Pubitemid 32506618)
26. Tsutamoto T, Wada A, Sakai H, Ishikawa C, Tanaka T, Hayashi M, et al. Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure. J Am Coll Cardiol 2006; 47:582-586. (Pubitemid 43170848)
27. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461-470. (Pubitemid 29135798)
28. Himelman RB, Chung WS, Chernoff DN, Schiller NB, Hollander H. Cardiac manifestations ofhuman immunodeficiency virus infection: a two-dimensional echocardiographic study. J Am Coll Cardiol 1989; 13:1030-1036. (Pubitemid 19091290)
29. Hsue PY, Hunt PW, Ho JE, Farah HH, Schnell A, Hoh R, et al. Impact ofHIV infection on diastolic function and left ventricular mass. Circ Heart Fail 2010; 3:132-139.
30. Butt AA, Chang CC, Kuller L, Goetz MB, Leaf D, Rimland D, et al. Risk ofheart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease. Arch Intern Med 2011; 171:737-743.
31. Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, et al. Pulmonary hypertension as arisk factor for death in patients with sickle cell disease. N Engl J Med 2004; 350:886-895. (Pubitemid 38252536)
32. Opravil M, Pechere M, Speich R, Joller-Jemelka HI, Jenni R, Russi EW, et al. HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study. Am J Respir Crit Care Med 1997; 155:990-995. (Pubitemid 27133414)
33. Zuber JP, Calmy A, Evison JM, Hasse B, Schiffer V, Wagels T, et al. Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy. Clin Infect Dis 2004; 38:1178-1185. (Pubitemid 38951268)
34. Degano B, Guillaume M, Savale L, Montani D, Jais X, Yaici A, et al. HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era. AIDS 2010; 24:67-75.
35. Weitzenblum E, Chaouat A, Canuet M, Kessler R. Pulmonary hypertension inchronic obstructive pulmonary disease and interstitial lung diseases. Semin Respir Crit Care Med 2009; 30:458-470.
36. Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E. Predictive factors ofhospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159:158-164. (Pubitemid 29036519)
37. Oswald-Mammosser M, Weitzenblum E, Quoix E, Moser G, Chaouat A, Charpentier C, et al. Prognostic factors inCOPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest 1995; 107: 1193-1198.
38. Stone AC, Machan JT, Mazer J, Casserly B, Klinger JR. Echocardiographic evidence ofpulmonary hypertension is associated with increased 1-year mortality in patients admitted with chronic obstructive pulmonary disease. Lung 2011; 189:207-212.
39. Fayngersh V, Drakopanagiotakis F, Dennis McCool F, Klinger JR. Pulmonary hypertension in astable community-based COPD population. Lung 2011; 189:377-382.
40. Akcay M, Yeter E, Durmaz T, Keles T, Akar Bayram N, Uyar M, et al. Treatment ofacute chronic obstructive pulmonary disease exacerbation improves right ventricle function. Eur J Echocardiogr 2010; 11:530-536.
41. Deeks SG, Kitchen CM, Liu L, Guo H, Gascon R, Narvaez AB, et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 2004; 104:942-947. (Pubitemid 39038012)
42. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, Jacobson LP, et al. Shorter survival inadvanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999; 179:859-870. (Pubitemid 29159331)
43. Liu Z, Cumberland WG, Hultin LE, Prince HE, Detels R, Giorgi JV. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16:83-92.
44. van Lelyved S, Gras L, Kesselring A, Zhang S, deWolf F, Wensing A, et al. Incomplete immune recovery on HAART is associated with significantly more cardiovascular events and a trend towards more non-AIDS related malignancies in Dutch ATHENA Cohort. In: 17th Conference on Retroviruses and Opportunistic Infections; 2010; San Francisco, California. pp. 714.
45. Guzman-Fulgencio M, Medrano J, Rallon N, Echeverria-Urabayen A, Miguel Benito J, Restrepo C, et al. Soluble markers ofinflammation are associated with Framingham scores in HIV-infected patients on suppressive antiretroviral therapy. J Infect 2011; 63:382-390.
46. Plaeger SF, Collins BS, Musib R, Deeks SG, Read S, Embry A. Immune activation in the pathogenesis of treated chronic HIV Disease: A workshop summary. AIDS Res Hum Retroviruses 2011. [Epub ahead of print].
47. Hunt PW, Deeks SG, Rodriguez B, Valdez H, Shade SB, Abrams DI, et al. Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy. AIDS 2003; 17:1907-1915. (Pubitemid 37070276)
48. Stockley RA. Progression ofchronic obstructive pulmonary disease: impact of inflammation, comorbidities and therapeutic intervention. Curr Med Res Opin 2009; 25: 1235-1245.
49. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences ininterleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153: 530-534.
50. Soon E, Holmes AM, Treacy CM, Doughty NJ, Southgate L, Machado RD, et al. Elevated levels ofinflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation 2010; 122:920-927.
51. Wang Z, Zheng T, Zhu Z, Homer RJ, Riese RJ, Chapman HA Jr, et al. Interferon gamma induction ofpulmonary emphysema in the adult murine lung. J Exp Med 2000; 192:1587-1600.
52. Shirai T, Suda T, Inui N, Chida K. Correlation between peripheral blood T-cell profiles and clinical and inflammatory parameters in stable COPD. Allergol Int 2010; 59:75-82.